|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash | ||||||||
| Prepayments | ||||||||
| Total Current Assets | ||||||||
| Cash and marketable securities held in trust | ||||||||
| TOTAL ASSETS | ||||||||
| Accrued expenses | ||||||||
| Amount due to sponsor | ||||||||
| Total Current Liabilities | ||||||||
| Deferred underwriting compensation | ||||||||
| TOTAL LIABILITIES | ||||||||
| Ordinary shares subject to possible redemption, 2,535,821 and 2,535,821 shares (at redemption price of $10.98 and $10.67 per share, respectively) | ||||||||
| Ordinary shares, no par value; 500,000,000 shares authorized; 1,750,000 and 1,750,000 shares issued and outstanding (excluding 2,535,821 and 2,535,821 shares, subject to possible redemption), respectively | ||||||||
| Accumulated deficit | ||||||||
| Total Shareholders’ Deficit | ||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
Loading...
